The Summit is the best event in Texas to learn about Texas Biotech Industry! AC2 sponsors a table at the Luminary Dinner and both the ACC Bioscience Incubator and Austin Community College faculty and students will attend. Below is the agenda for the event. More information can be be found at the Texas Healthcare Bioscience Institute website.
February 11, 2019- Summit and Luminary Dinner @ Stephen F. Austin Hotel
Lunch: 12:30 to 12:50 Lunch Continues | Texas’ Innovation EcoSystem and Its Impact on the Texas Economy
The Texas’ Innovation Ecosystem will include conversations from industry experts from different regions of Texas coming together to highlight the innovation taking place across and how it enables Texas to be a world-class leader in healthcare and biotechnology.
Emma Schwartz, President and Executive Director, Medical Center of the Americas Frank Grassler, Vice President for Technology Development, UT Southwestern Tom Luby, PhD, Head of JLABS @ TMC
Chris Laing, PhD, Executive Director, Capital City Innovation
Larry Schlesinger, MD, President and CEO, Texas Biomedical Research Institute Moderator: Ann Tanabe, CEO, BioHouston
The Success, Impact and Future of The Cancer Prevention and Research Institute of Texas
As the second largest publicly funded cancer research organization in the nation, CPRIT’s investments are showing a significant impact on Texas’ life sciences intellectual capital and the biotech industry by increasing innovation, creating clinical trials, increasing prevention opportunities, providing jobs and positively impacting the Texas economy. CPRIT is now looking at future funding prospects and new opportunities for a reauthorization to enable the continuation of its success.
Wayne Roberts, CEO, Cancer Prevention and Research Institute of Texas (CPRIT)
The Texas Innovation Corridor: Powering the future in the heart of Texas
Anchored to the north by Austin’s Silicon Hills and to the south by San Antonio’s biotech industry, the flourishing Texas Innovation Corridor boasts unprecedented growth, job creation, new business startups and economic expansion. President Denise Trauth discusses the future of the corridor, and the innovative research and development opportunities Texas State is contributing to the growth of the region.
President Denise Trauth, PhD, Texas State University
Business of Research and Development and Its Impact on Innovation
Research and development are the drivers of innovation. This panel will discuss the inner-workings of bringing products to the marketplace and how collaboration creates a world class environment for Texas bioscience innovation.
Pete Pellerito, Senior Policy Adviser, Federal/State Economic Development & Technology Transfer Lead, Biotechnology Innovation Organization (BIO)
COL (ret) George E. Peoples, MD, Founder and CEO, Cancer Insight
Benjamin Perkins, Managing Director, pHPartners
Jorge Varela, CEO, BioNorthTX
Moderator: Andrew Strong, Partner, Pillsbury
Texas Life Sciences and the 86th Legislative Session
The role of healthcare and innovation and its implications on legislation and the state budget.
Representative Donna Howard
Chairman Stephanie Klick
Chairman Senfronia Thompson
Moderator: Robert Popovian, PharmD, Vice President, US Government Relations, Pfizer
The Cost of Healthcare
Private sector solutions that will increase access, reduce healthcare costs, improve patient affordability and support biopharmaceutical innovation.
Robert Popovian, PharmD, Vice President, US Government Relations, Pfizer
President Peter Pisters, MD, UT MD Anderson Cancer Center
Summit closing remarks
Reception and Luminary Awards Dinner
Honoree: Nobel Laureate Jim P. Allison, Ph.D., Immunotherapy Researcher, UT MD Anderson Cancer Center
Honoree: Chairman John Zerwas, MD, Texas House of Representatives
Honoree: Senator Kirk Watson, Texas Senate
Honoree: Patient Advocate Debra Miller, Founder and CEO, CureDuchenn